GL1X · GenesisL1 explorer

MolNFT v1 · #147838 · protein

Crystal structure of btk kinase domain complexed with N-[2-methyl-3- [4-methyl-6-[4-(4-methylpiperazine-1-CARBONYL)ANILINO]-5-oxo-pyrazin- 2-YL]PHENYL]-4-(1-PIPERIDYL)BENZAMIDE

6EP9 · Tyrosine-protein kinase btk: “Crystal structure of btk kinase domain complexed with N-[2-methyl-3…”. X-ray diffraction, 1 ligand (BNB), 2 pockets (best druggability 0.70). MolNFT v1 #147838 on GenesisL1: 3D structure, binding sites…

PDB
6EP9
Type
protein
Length
263 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase btk
EC
2.7.10.2
UniProt
Q06187
Ligands
BNB
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase btk (EC 2.7.10.2)protein26344% helix, 17% strandQ06187

Ligands and binding sites

  • BNB · N-[2-methyl-3-[4-methyl-6-[4-(4-methylpiperazine-1-carbonyl)anilino]-5-oxo-pyrazin-2-yl]phenyl]-4-(1-piperidyl)benzamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14040.700.8148BNB
2880.550.8517empty

Compared structures

  • 6EP9 · Crystal structure of BTK kinase domain complexed with… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q06187 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase btk (Q06187) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.